Suppr超能文献

组织血管紧张素转换酶在肾微循环调控中作用的视频显微镜评估

Video-microscopic assessment of the role of tissue angiotensin-converting enzyme in the control of the renal microcirculation.

作者信息

ter Wee P M, Forster H G, Epstein M

机构信息

Department of Veterans Affairs Medical Center, and Division of Nephrology, University of Miami School of Medicine, Florida 33125, USA.

出版信息

J Pharmacol Exp Ther. 1997 Apr;281(1):434-9.

PMID:9103527
Abstract

In the present study, we assessed the role of tissue angiotensin-converting enzyme as a determinant of intrarenal hemodynamics by using the angiotensin-converting enzyme inhibitor trandolaprilat and the angiotensin II receptor antagonist losartan. Afferent and efferent arteriolar diameters were measured with computer-assisted vessel imaging in isolated perfused hydronephrotic rat kidneys. In response to the addition of 1.0 nM angiotensin I, afferent arterioles constricted by 27.3 +/- 2.4% and efferent arterioles by 20.9 +/- 2.4%. These constrictions were similar to those observed after the administration of 0.3 nM angiotensin 11 (33.7 +/- 2.3% and 20.9 +/- 2.4% in afferent and efferent arterioles, respectively). Pretreatment with the angiotensin-converting enzyme inhibitor trandolaprilat (0.1-10 microM) blunted the angiotensin I-induced constriction of afferent arterioles (12.7 +/- 1.4%) and completely abolished the angiotensin I-induced constriction of efferent arterioles. Subsequent addition of angiotensin II to the perfusate resulted in a marked decrease of afferent (39.9 +/- 1.8%) and efferent (27.8 +/- 3.3%) arteriolar diameters. Pretreatment with the angiotensin II receptor antagonist losartan completely blocked the angiotensin I-induced constriction of both afferent and efferent arterioles. Collectively, these data suggest that angiotensin I affects renal microvessels through its conversion to angiotensin II, mediated by locally available tissue angiotensin-converting enzyme, which subserves the local control of the renal microcirculation.

摘要

在本研究中,我们通过使用血管紧张素转换酶抑制剂群多普利拉和血管紧张素II受体拮抗剂氯沙坦,评估了组织血管紧张素转换酶作为肾内血流动力学决定因素的作用。在分离灌注的肾积水大鼠肾脏中,采用计算机辅助血管成像测量入球小动脉和出球小动脉直径。加入1.0 nM血管紧张素I后,入球小动脉收缩27.3±2.4%,出球小动脉收缩20.9±2.4%。这些收缩与给予0.3 nM血管紧张素II后观察到的收缩相似(入球小动脉和出球小动脉分别为33.7±2.3%和20.9±2.4%)。用血管紧张素转换酶抑制剂群多普利拉(0.1 - 10 microM)预处理可减弱血管紧张素I引起的入球小动脉收缩(12.7±1.4%),并完全消除血管紧张素I引起的出球小动脉收缩。随后向灌注液中加入血管紧张素II导致入球小动脉(39.9±1.8%)和出球小动脉(27.8±3.3%)直径显著减小。用血管紧张素II受体拮抗剂氯沙坦预处理可完全阻断血管紧张素I引起的入球小动脉和出球小动脉收缩。总体而言,这些数据表明血管紧张素I通过其在局部组织血管紧张素转换酶介导下转化为血管紧张素II来影响肾微血管,该酶参与肾微循环的局部调控。

相似文献

10
Renal segmental microvascular responses to ANG II in AT1A receptor null mice.AT1A受体基因敲除小鼠肾节段性微血管对血管紧张素II的反应
Am J Physiol Renal Physiol. 2003 Mar;284(3):F538-45. doi: 10.1152/ajprenal.00340.2002. Epub 2002 Nov 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验